News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
637,422 Results
Type
Article (60964)
Company Profile (78)
Press Release (576380)
Section
Business (173886)
Career Advice (2718)
Deals (32489)
Drug Delivery (91)
Drug Development (76763)
Employer Resources (148)
FDA (14875)
Job Trends (13852)
News (305025)
Policy (28948)
Tag
Academia (2869)
Alliances (43184)
Alzheimer's disease (1227)
Approvals (14851)
Artificial intelligence (169)
Bankruptcy (282)
Best Places to Work (10834)
Breast cancer (201)
Cancer (1485)
Cardiovascular disease (112)
Career advice (2298)
CAR-T (109)
Cell therapy (318)
Clinical research (61506)
Collaboration (547)
Compensation (194)
COVID-19 (2540)
C-suite (146)
Data (1442)
Diabetes (173)
Diagnostics (5994)
Earnings (58911)
Employer resources (131)
Events (92727)
Executive appointments (508)
FDA (15647)
Funding (509)
Gene therapy (209)
GLP-1 (582)
Government (4403)
Healthcare (18165)
Infectious disease (2627)
Inflammatory bowel disease (114)
Interviews (522)
IPO (14741)
Job creations (3409)
Job search strategy (1936)
Layoffs (452)
Legal (6404)
Lung cancer (214)
Manufacturing (194)
Medical device (12540)
Medtech (12545)
Mergers & acquisitions (18051)
Metabolic disorders (449)
Neuroscience (1573)
NextGen: Class of 2025 (6366)
Non-profit (4313)
Northern California (1687)
Obesity (245)
Opinion (213)
Parkinson's disease (101)
Patents (129)
People (58877)
Phase I (19335)
Phase II (27144)
Phase III (19825)
Pipeline (579)
Postmarket research (2470)
Preclinical (8210)
Radiopharmaceuticals (242)
Rare diseases (272)
Real estate (5980)
Regulatory (19670)
Research institute (2389)
Resumes & cover letters (405)
Southern California (1496)
Startups (3336)
United States (15221)
Vaccines (559)
Weight loss (166)
Date
Today (143)
Last 7 days (394)
Last 30 days (1890)
Last 365 days (31989)
2025 (1726)
2024 (32349)
2023 (36422)
2022 (46769)
2021 (51650)
2020 (50794)
2019 (44842)
2018 (34112)
2017 (30785)
2016 (30143)
2015 (35511)
2014 (28435)
2013 (25009)
2012 (26266)
2011 (26552)
2010 (24980)
Location
Africa (867)
Arizona (145)
Asia (38468)
Australia (6787)
California (3828)
Canada (1427)
China (341)
Colorado (182)
Connecticut (196)
Europe (87507)
Florida (569)
Georgia (142)
Illinois (422)
Indiana (218)
Maryland (640)
Massachusetts (2852)
Michigan (184)
Minnesota (266)
New Jersey (1125)
New York (1098)
North Carolina (787)
Northern California (1687)
Ohio (145)
Pennsylvania (893)
South America (1173)
Southern California (1496)
Texas (582)
Utah (115)
Washington State (389)
637,422 Results for "university of hong kong".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hong Kong Pharma Digital Technology Holdings Limited Announces Closing of Initial Public Offering
January 16, 2025
·
5 min read
Press Releases
Hong Kong Pharma Digital Technology Holdings Limited Announces Pricing of Initial Public Offering
January 14, 2025
·
5 min read
Press Releases
Tune Therapeutics Receives Approval to Initiate Clinical Trial in Hong Kong for HepB Epigenetic Silencer
January 7, 2025
·
2 min read
Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment
Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announces advancement in its proprietary MEAI- based binge behavior regulator program through the granting of patent approval in Hong Kong by the Hong Kong Patent Office
June 28, 2024
·
4 min read
Press Releases
Santhera Announces Approval in Hong Kong for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy
December 20, 2024
·
5 min read
Genetown
T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau Distributor
T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, announced the execution of a territory exclusive distribution agreement in Hong Kong and Macau.
June 25, 2024
·
4 min read
Press Releases
Fangzhou Inc. Announces Inclusion of Its Shares in Hang Seng Hong Kong-Listed Biotech Index
December 3, 2024
·
2 min read
Press Releases
Register Now for the Microfluidics for Biomedical Innovation Conference 2025: Hear from KOLs from the US, Europe and Across Asia-Pacific (Sha Tin, Hong Kong - February 7-8, 2025)
January 20, 2025
·
3 min read
Policy
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
Shanghai Junshi Biosciences Co., Ltd announced that the Drug Office, Department of Health, the Government of the Hong Kong Special Administrative Region has recently accepted the New Drug Application for toripalimab in combination with cisplatin and gemcitabine for the first-line treatment of adults with metastatic or recurrent locally advanced nasopharyngeal carcinoma.
April 24, 2024
·
8 min read
Press Releases
Zai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore
January 10, 2025
·
9 min read
1 of 63,743
Next
